119 related articles for article (PubMed ID: 3476806)
1. [24-year survival in chronic myeloid leukemia].
Müller L; Hehlmann R
Klin Wochenschr; 1987 Jul; 65(14):673-6. PubMed ID: 3476806
[TBL] [Abstract][Full Text] [Related]
2. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
[TBL] [Abstract][Full Text] [Related]
3. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.
Koller CA; Miller DM
N Engl J Med; 1986 Dec; 315(23):1433-8. PubMed ID: 2431313
[TBL] [Abstract][Full Text] [Related]
4. [Occurrence of non-Hodgkin's lymphoma in chronic myeloid leukemia].
Martoïa R; Lamy T; Delmaire P; Algayres JP; Rougier Y; Laurens A
Rev Med Interne; 1987; 8(5):471-4. PubMed ID: 3481866
[TBL] [Abstract][Full Text] [Related]
5. [Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles].
Cervantes F; Rozman C; Nomdedeu B; Blade J; Montserrat E
Rev Clin Esp; 1986 Jan; 178(1):4-7. PubMed ID: 3457411
[No Abstract] [Full Text] [Related]
6. Therapy of the blast phase of chronic granulocytic leukemia with mithramycin and hydroxyurea.
Queisser W; Herrmann F; Lindemann A; Anger B; Hiddemann W; Krey U
Onkologie; 1988 Jun; 11(3):145-6. PubMed ID: 2970612
[No Abstract] [Full Text] [Related]
7. Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion.
Singer CR; McDonald GA; Douglas AS
Br J Haematol; 1984 Jun; 57(2):309-13. PubMed ID: 6587904
[TBL] [Abstract][Full Text] [Related]
8. [Cytogenetic and therapeutic results of a protocol including splenectomy and intensive polychemotherapy in Ph'-positive chronic myeloid leukemia].
Cervantes F; Rozman C; Ballesta F; Milá M
Sangre (Barc); 1986; 31(3):297-302. PubMed ID: 3462920
[No Abstract] [Full Text] [Related]
9. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
[TBL] [Abstract][Full Text] [Related]
10. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.
Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Smith TL; Talpaz M; Beran M; Cork A; Trujillo JM; Freireich EJ
Cancer; 1986 Nov; 58(9):2023-30. PubMed ID: 3463397
[TBL] [Abstract][Full Text] [Related]
13. Induction of sister chromatid exchanges and chromosomal aberrations by busulfan in Philadelphia chromosome-positive chronic myeloid leukemia and normal bone marrow.
Becher R; Prescher G
Cancer Res; 1988 Jun; 48(12):3435-9. PubMed ID: 3163516
[TBL] [Abstract][Full Text] [Related]
14. Management of chronic myelogenous leukemia.
Griffin JD
Semin Hematol; 1986 Jul; 23(3 Suppl 1):20-6. PubMed ID: 3526559
[No Abstract] [Full Text] [Related]
15. Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.
Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H
Blut; 1988 Feb; 56(2):87-91. PubMed ID: 3277680
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
Sullivan JR; Hurley TH; Bolton JH
Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
[TBL] [Abstract][Full Text] [Related]
17. Prolonged remission of accelerated phase Philadelphia chromosome negative chronic myeloid leukemia following autologous recovery of normal hematopoietic elements after busulfan/cyclophosphamide and allogeneic marrow transplantation.
Kapoor N; Keever CA; Hsu SH; Copelan EA; Tutschka PJ
Bone Marrow Transplant; 1992 Feb; 9(2):143-5. PubMed ID: 1349249
[TBL] [Abstract][Full Text] [Related]
18. The combined use of busulfan and hydroxyurea in the treatment of chronic myeloid leukemia.
Jim RT
Hawaii Med J; 1990 Apr; 49(4):133-4. PubMed ID: 2341244
[No Abstract] [Full Text] [Related]
19. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
Kantarjian HM; Keating MJ; Talpaz M; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
Am J Med; 1987 Sep; 83(3):445-54. PubMed ID: 3477958
[TBL] [Abstract][Full Text] [Related]
20. Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron.
Walters RS; Kantarjian HM; Keating MJ; Talpaz M; Childs CC; McCredie KB; Freireich EJ
Cancer; 1987 Oct; 60(8):1708-12. PubMed ID: 3477315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
